Clinical Trial Update: Combination Stem Cell (MESENDO) Therapy for Utilization and Rescue of Infarcted Myocardium [Phase 1]

View source ↗

Summary

Phase 1 trial of MESENDO stem cell therapy for rescue of infarcted myocardium in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Arteriosclerosis
• Coronary Artery Disease
• Coronary Atherosclerosis
• Coronary Disease

Drugs mentioned

• MESENDO

Snippet

Sponsor: TCA Cellular Therapy | Conditions: Coronary Artery Disease, Coronary Arteriosclerosis | Phase 1 | Status: COMPLETED